MINERALYS THERAPEUTICS INC (MLYS:NASDAQ)
$28.38 -0.58 (-2.0028%)
Analysed MINERALYS THERAPEUTICS INC (MLYS:NASDAQ) News Sources
Mineralys Therapeutics (MLYS) Shares Encouraging Data for Lorundrostat Clinical Efficacy
05-06-2026
yahoo.com
Mineralys Deepens Lorundrostat Bet With Royalty Buyout And New Data
07-06-2026
yahoo.com
Mineralys Therapeutics to Present Late-Breaking Data on Lorundrostat at The Endocrine Society Annual Meeting (ENDO 2026)
08-06-2026
yahoo.com
Mineralys Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
08-06-2026
yahoo.com
Mineralys Therapeutics (MLYS) to Repurchase Potential Royalties for Lorundrostat
11-06-2026
yahoo.com
Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026)
14-06-2026
yahoo.com
Mineralys Therapeutics (MLYS) Prices $150M Public Offering of Common Stock
17-06-2026
yahoo.com
What a $350,000 Insider Sale Might Mean for Mineralys Ahead of December FDA Decision
23-06-2026
fool.com
Is Mineralys Therapeutics, Inc. (MLYS) Stock a Biotech Opportunity With Lorundrostat’s Expanding Cardiovascular Potential?
02-07-2026
yahoo.com
A $500 Million Funding Deal Could Make Mineralys Therapeutics (MLYS) Stock A Multibagger
03-07-2026
yahoo.com
What is the current price of MINERALYS THERAPEUTICS INC (MLYS:NASDAQ)?
The current price of MINERALYS THERAPEUTICS INC (MLYS:NASDAQ) is $28.38.
MINERALYS THERAPEUTICS INC (MLYS:NASDAQ) absolute price change since previous trading day?
The absolute price change of MINERALYS THERAPEUTICS INC (MLYS:NASDAQ) since the previous trading day is $-0.58.
MINERALYS THERAPEUTICS INC (MLYS:NASDAQ) percentage price change since previous trading day?
The percentage price change of MINERALYS THERAPEUTICS INC (MLYS:NASDAQ) since the previous trading day is -2.0028%.
What is the most recent average sentiment score for MINERALYS THERAPEUTICS INC (MLYS:NASDAQ)?
The most recent average sentiment score for MINERALYS THERAPEUTICS INC (MLYS:NASDAQ) is 87 out of 100.
What is the most recent average sentiment for MINERALYS THERAPEUTICS INC (MLYS:NASDAQ)?
The most recent sentiment for MINERALYS THERAPEUTICS INC (MLYS:NASDAQ) is .
SEC-8K** Filing Available For MINERALYS THERAPEUTICS INC (MLYS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.